(RTTNews) - ANI Pharmaceuticals Inc. (ANIP) said on Tuesday that it has received FDA approval for a generic version of Pfizer's Mycobutin. Mycobutin contains 150 mg of the Rifamycin antimycobacterial ...
Pharmaceutical firm Lupin today said it has received final approval from US health regulator to market the generic?version?of Mycobutin?capsules of Pharmacia?and?Upjohn?Company that are used while ...
Shares of Lupin gained more than a percent intraday on Wednesday on receiving final approval from US Food and Drug Administration (USFDA) for its Rifabutin capsules. "...received final approval for ...
Lupin Ltd has informed BSE regarding a Press Release dated February 26, 2014, titled "Lupin Receives FDA Approval for Generic Mycobutin® Capsules". Lupin has received final approval for its Rifabutin ...
ANI has obtained the Food and Drug Administration’s clearance for rifabutin capsules, 150 mg. The medication is the generic of Pfizer’s Mycobutin. It is indicated for the prevention of disseminated ...
Lupin says the approval from the USFDA is for Rifabutin Capsules USP, in strength of 150 mg. Photo: Ramesh Pathania/Mint The approval from the US Food and Drug Administration (FDA) is for Rifabutin ...
WASHINGTON (dpa-AFX) - ANI Pharmaceuticals Inc. (ANIP) said on Tuesday that it has received FDA approval for a generic version of Pfizer's Mycobutin. Mycobutin contains 150 mg of the Rifamycin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results